Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
Risks With Untreated ITP
3:39
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
Risks With Untreated ITP
3:39
|
A Case of Immune Thrombocytopenia
3:55
|
Presenting With Immune Thrombocytopenia
4:07
|
Behind the Mystery of Chronic Immune Thrombocytopenia (ITP): A Blood Platelet Disorder
20:11
|
ITP Treatment Selection Criteria and Treatment Goals
6:59
|
Bleeding-related episodes common in elderly with immune thrombocytopenia
5:08
|
Frontline Therapy for Immune Thrombocytopenia
3:33
|
The Future of ITP Treatment
6:44
|
Rozanolixizumab to Treat Immune Thrombocytopenia
5:46
|
ITP: Second-Line Therapy
2:26
|
ITP awareness video
7:26
|
How do genes influence the development of chronic idiopathic thrombocytopenic purpura?
5:33
|
Differentiating immune thrombocytopenia from IPD and PID
1:28
|
What are the Challenges of Treating and Managing ITP?
3:15
|
Immune Thrombocytopenia: Impact of the EXTEND Trial
4:20
|
Is bleeding a problem in ITP Dr Nichola Cooper
16:59
|
Are ITP patients at higher risk for COVID-19 complications?
0:33
|
ASH Highlights: Efgartigimod Safe and Effective in Treating Immune Thrombocytopenia (ITP)
2:55
|
Duration of Platelet Recovery With TPO-RAs
2:10
|
What demographic of people does ITP affect?
0:47
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa
